{
\def\sym#1{\ifmmode^{#1}\else\(^{#1}\)\fi}
\begin{tabular}{l*{1}{ccccc}}
\hline\hline
                    &        mean&         p50&          sd&         min&         max\\
\hline
Type-2 Diabetes (Monitor) - Population Eligible, Diagnosis E11&          85&          82&          47&           1&         270\\
Type-2 Diabetes (Monitor) - Patients Served&          64&        59.5&          42&           0&         210\\
Type-2 Diabetes (Monitor) - Coverage Ratio&          76&          87&          27&           0&         100\\
Type-2 Diabetes (Medication) - Population Eligible&          72&          70&          39&           1&         214\\
Type-2 Diabetes (Medication) - Patients Served&          50&        49.5&          28&           1&         151\\
Type-2 Diabetes (Medication) - Coverage Ratio&          71&          71&          10&          26&         100\\
Hypertension-All (Monitor) - Population Eligible&         128&         109&          90&           0&         534\\
Hypertension-All (Monitor) - Patients Served&          98&          80&          80&           0&         520\\
Hypertension-All (Monitor) - Coverage Ratio&          73&          82&          26&           0&         100\\
Hypertension-All (Medication) - Total Prescriptions Made For Diagnosis I10-I15&        3086&        3088&        1543&          19&        8140\\
Hypertension-All (Medication) - Active Ingredient Based Prescription Made&        3047&        3062&        1542&          19&        8140\\
Hypertension-All (Medication) - Share Of Active Infgredient Based Prescription&          99&         100&           7&          12&         100\\
Hypertension-Med (Monitor) - Population Eligible&         218&         202&         142&           4&         725\\
Hypertension-Med (Monitor) - Patients Served&         139&       114.5&         107&           0&         583\\
Hypertension-Med (Monitor) - Coverage Ratio&          67&          78&          28&           0&         100\\
Hypertension-Med (Medication) - Population Eligible (Medium To High Risk)&         268&       258.5&         162&           4&         772\\
Hypertension-Med (Medication) - Patients Served&         220&         216&         128&           1&         588\\
Hypertension-Med (Medication) - Coverage Ratio&          83&          84&           8&          25&         100\\
Hypertension-High (Monitor) - Population Eligible&          50&          33&          51&           0&         427\\
Hypertension-High (Monitor) - Patients Served&          37&        22.5&          41&           0&         317\\
Hypertension-High (Monitor) - Coverage Ratio&          75&          86&          28&           0&         100\\
Hypothyreosis (Monitor) - Population Eligible&          64&        56.5&          37&           0&         307\\
Hypothyreosis (Monitor) - Patients Served&          55&          49&          33&           0&         295\\
Hypothyreosis (Monitor) - Coverage Ratio&          87&          93&          16&           0&         100\\
Myocardial Infarction (Monitor) - Population Eligible&          26&          24&          16&           0&          83\\
Myocardial Infarction (Monitor) - Patients Served&          21&          18&          15&           0&          76\\
Myocardial Infarction (Monitor) - Coverage Ratio&          79&          93&          29&           0&         100\\
Myocardial Infarction (Medication) - Beta-Blockers Population Eligible&          26&          24&          16&           0&          84\\
Myocardial Infarction (Medication) - Beta Blockers Patients Served&          17&          16&          11&           0&          60\\
Myocardial Infarction (Medication) - Coverage Ratio&          68&          68&          15&           0&         100\\
Myocardial Infarction (Medication) - Statins - Population Eligible&          26&          24&          16&           0&          84\\
Myocardial Infarction (Medication) - Statins - Patients Served&          17&          16&          11&           0&          64\\
Myocardial Infarction (Medication) - Coverage Ratio&          67&          67&          16&           0&         100\\
\hline
Observations        &         786&            &            &            &            \\
\hline\hline
\end{tabular}
}
